Indoor air quality at home
In development [GID-QS10113] Expected publication date: TBC
Search results
2589 results
-
-
Joint replacement (primary): hip, knee and shoulder
In development [GID-QS10090] Expected publication date: TBC
-
Neonatal parenteral nutrition
In development [GID-QS10087] Expected publication date: TBC
-
Perioperative care
In development [GID-QS10094] Expected publication date: TBC
-
Fetal alcohol spectrum disorder
In development [GID-QS10139] Expected publication date: 30 July 2021
-
Pernicious anaemia
Proposed [GID-QS10130] Expected publication date: TBC
-
Tinnitus
Proposed [GID-QS10091] Expected publication date: TBC
-
Heart valve disease in adults
Proposed [GID-QS10101] Expected publication date: TBC
-
Diverticular disease
Proposed [GID-QS10086] Expected publication date: TBC
-
Acne
Proposed [GID-QS10036] Expected publication date: TBC
-
Pain management (young people and adults)
Proposed [GID-QS10093] Expected publication date: TBC
-
Adrenal dysfunction
Proposed [GID-QS10038] Expected publication date: TBC
-
Pancreatitis (including acute pancreatitis)
Proposed [GID-QS10085] Expected publication date: TBC
-
Thyroid disease
Proposed [GID-QS10088] Expected publication date: TBC
-
Primary hyperparathyroidism
Proposed [GID-QS10089] Expected publication date: TBC
-
Sleep disordered breathing
Proposed [GID-QS10096] Expected publication date: TBC
-
Managing symptoms with an uncertain cause
Proposed [GID-QS10103] Expected publication date: TBC
-
Safe prescribing and withdrawal management of prescribed drugs associated with dependence and withdrawal
Proposed [GID-QS10106] Expected publication date: TBC
-
Readmission to ICU within 48hrs
Proposed [GID-QS10105] Expected publication date: TBC
-
Secondary care management of malignant hypertension
Proposed [GID-QS10107] Expected publication date: TBC
-
Prevention of dementia
Proposed [GID-QS10109] Expected publication date: TBC
-
Pelvic floor dysfunction
Proposed [GID-QS10129] Expected publication date: TBC
-
Shared decision-making: practical guidance for health and social care professionals
Proposed [GID-QS10097] Expected publication date: TBC
-
Abortion care
In development [GID-QS10084] Expected publication date: 26 January 2021
-
Brain tumours (primary) and brain metastases in adults
In development [GID-QS10092] Expected publication date: TBC
-
Colorectal cancer (QS update)
In development [GID-QS10141] Expected publication date: TBC
-
Depression in adults (update)
Proposed [GID-QS10057] Expected publication date: TBC
-
Abdominal aortic aneurysm
Proposed [GID-QS10035] Expected publication date: TBC
-
Adults with lifelong or very severe hearing or visual impairment: health, well-being and social care
Proposed [GID-QS10144] Expected publication date: TBC
-
Advocacy services for adults with health and social care needs
Proposed [GID-QS10145] Expected publication date: TBC
-
Children and young people with disabilities and severe complex needs: integrated health and social care support
Proposed [GID-QS10146] Expected publication date: TBC
-
Safeguarding adults in care homes
Proposed [GID-QS10147] Expected publication date: TBC
-
Social work interventions for adults with complex needs (including learning disabilities) and mental health needs
Proposed [GID-QS10148] Expected publication date: TBC
-
Supporting independent living and preventing isolation in adults of working age with social care needs
Proposed [GID-QS10149] Expected publication date: TBC
-
Venous thromboembolic diseases (QS update)
In development [GID-QS10142] Expected publication date: 27 April 2021
-
Workplace health: long-term sickness absence and capability to work
In development [GID-QS10114] Expected publication date: TBC
-
Supporting adult carers
In development [GID-QS10128] Expected publication date: TBC
-
myCOPD for self-management of chronic obstructive pulmonary disease (MIB214)
NICE has developed a medtech innovation briefing (MIB) on myCOPD for self-management of chronic obstructive pulmonary disease
-
Renin-angiotensin system drugs: dual therapy (KTT2)
The key therapeutic topic renin-angiotensin system drugs: dual therapy has been retired from the 2017 update of medicines optimisation: key therapeutic topics. The version published in 2016 is available here for information but it has not been updated since February 2016. Like all the other key therapeutic topics it is not formal NICE guidance .
-
Minocycline (KTT11)
The key therapeutic topic minocycline has been retired from the 2016 update of medicines optimisation: key therapeutic topics. The version published in 2015 is available here for information but it has not been updated since January 2015. Like all the other key therapeutic topics it is not formal NICE guidance .
-
Laxatives (KTT1)
The key therapeutic topic laxatives has been retired from the 2016 update of medicines optimisation: key therapeutic topics. The version published in 2015 is available here for information but it has not been updated since January 2015. Like all the other key therapeutic topics it is not formal NICE guidance .
-
First-choice antidepressant use in adults with depression or generalised anxiety disorder (KTT8)
The key therapeutic topic first-choice antidepressant use in adults with depression or generalised anxiety disorder has been retired from the 2017 update of medicines optimisation: key therapeutic topics. The version published in 2016 is available here for information but it has not been updated since February 2016. Like all the other key therapeutic topics it is not formal NICE guidance .
-
Suicide prevention: optimising medicines and reducing access to medicines as a means of suicide (KTT24)
This document summarises the evidence base on suicide prevention: optimising medicines and reducing access to medicines as a means of suicide . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .
-
Shared decision making (KTT23)
This document summarises the evidence base on shared decision making . It is a key therapeutic topic that has been identified to support Medicines Optimisation. It is not formal NICE guidance .
-
Chemotherapy dose standardisation (KTT22)
This document summarises the evidence base on chemotherapy dose standardisation . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .
-
Medicines optimisation in chronic pain (KTT21)
This document summarises the evidence base on medicines optimisation in chronic pain . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .
-
Safer insulin prescribing (KTT20)
This document summarises the evidence base on safer insulin prescribing . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .
-
Psychotropic medicines in people with learning disabilities whose behaviour challenges (KTT19)
This document summarises the evidence base on psychotropic medicines in people with learning disabilities whose behaviour challenges . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .
-
Multimorbidity and polypharmacy (KTT18)
This document summarises the evidence base on multimorbidity and polypharmacy . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .
-
Acute kidney injury (AKI): use of medicines in people with or at increased risk of AKI (KTT17)
This document summarises the evidence base on the use of medicines in people with or at increased risk of acute kidney injury . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .